Log in to save to my catalogue

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519685

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

About this item

Full title

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2020-09, Vol.11 (9), p.802-802, Article 802

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. NAFLD stages range from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) which can progress to cirrhosis and hepatocellular carcinoma. One of the crucial events clearly involved in NAFLD progression is the lipotoxicity resulting fro...

Alternative Titles

Full title

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519685

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519685

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-020-03003-w

How to access this item